The paper reports unique metabolic subtypes in 72% of the children with autism in the study. The addition of a third validated test panel for these metabolic subtypes results in an overall accuracy of the NPDX Test Panels of 81%. Each subtype provides insight into the unique metabolic dysregulation of the child and helps inform more precise treatment based upon the biology of the individual.
We improve the lives of children and families living with autism spectrum disorder (ASD) and other neurological disorders by providing tools for earlier diagnosis and more precise treatment. We continue to look for ways to identify more children with ASD and to advise treatment that addresses their specific needs. Read read our publication in Autism Research.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.